Kaiser, J. Customized tumour vaccines preserve most cancers in verify. Science 356, 122 (2017).
Pulendran, B. & Davis, M. M. The science and drugs of human immunology. Science 369, eaay4014 (2020).
Ci, T. et al. Cryo-shocked most cancers cells for focused drug supply and vaccination. Sci. Adv. 6, eabc3013 (2020).
Jiang, Y. et al. Engineered cell-membrane-coated nanoparticles instantly current tumor antigens to advertise anticancer immunity. Adv. Mater. 32, e2001808 (2020).
Guo, J. et al. Most cancers vaccines from cryogenically silicified tumour cells functionalized with pathogen-associated molecular patterns. Nat. Biomed. Eng. 6, 19–31 (2022).
Harari, A., Graciotti, M., Bassani-Sternberg, M. & Kandalaft, L. E. Antitumour dendritic cell vaccination in a priming and boosting strategy. Nat. Rev. Drug Discov. 19, 635–652 (2020).
Marar, C., Starich, B. & Wirtz, D. Extracellular vesicles in immunomodulation and tumor development. Nat. Immunol. 22, 560–570 (2021).
Cheng, L. & Hill, A. F. Therapeutically harnessing extracellular vesicles. Nat. Rev. Drug Discov. 21, 379–399 (2022).
Jhunjhunwala, S., Hammer, C. & Delamarre, L. Antigen presentation in most cancers: insights into tumour immunogenicity and immune evasion. Nat. Rev. Most cancers 21, 298–312 (2021).
Roth, G. A. et al. Designing spatial and temporal management of vaccine responses. Nat. Rev. Mater. 7, 174–195 (2022).
Ma, L. et al. Immunotherapy and prevention of most cancers by nanovaccines loaded with whole-cell parts of tumor tissues or cells. Adv. Mater. 33, e2104849 (2021).
Saxena, M., van der Burg, S. H., Melief, C. J. M. & Bhardwaj, N. Therapeutic most cancers vaccines. Nat. Rev. Most cancers 21, 360–378 (2021).
Zhang, X., Cui, H., Zhang, W., Li, Z. & Gao, J. Engineered tumor cell-derived vaccines in opposition to most cancers: the artwork of combating poison with poison. Bioact. Mater. 22, 491–517 (2023).
Web page, D. B. et al. Glimpse into the longer term: harnessing autophagy to advertise antitumour immunity with the DRibbles vaccine. J. Immunother. Most cancers 4, 25 (2016).
Wenger, T. et al. Autophagy inhibition promotes faulty neosynthesized proteins storage in ALIS, and induces redirection towards proteasome processing and MHCI-restricted presentation. Autophagy 8, 350–363 (2012).
Yi, Y. et al. Autophagy-assisted antigen cross-presentation: autophagosome because the argo of shared tumour-specific antigens and DAMPs. Oncoimmunology 1, 976–978 (2012).
Hou, W. et al. Unusual attractors: DAMPs and autophagy hyperlink tumor cell loss of life and immunity. Cell Loss of life Dis. 4, e966 (2013).
Yamamoto, Okay. et al. Autophagy promotes immune evasion of pancreatic most cancers by degrading MHC-I. Nature 581, 100–105 (2020).
MacNabb, B. W. et al. Dendritic cells can prime antitumour CD8+ T cell responses via main histocompatibility advanced cross-dressing. Immunity 55, 982–997.e8 (2022).
Dersh, D., Holly, J. & Yewdell, J. W. A couple of good peptides: MHC class I-based most cancers immunosurveillance and immunoevasion. Nat. Rev. Immunol. 21, 116–128 (2021).
Li, Y. et al. Tumor-derived autophagosome vaccine: mechanism of cross-presentation and therapeutic efficacy. Clin. Most cancers Res. 17, 7047–7057 (2011).
Li, Y. et al. Environment friendly cross-presentation is determined by autophagy in tumor cells. Most cancers Res. 68, 6889–6895 (2008).
Ye, Z. et al. Manipulation of PD-L1 endosomal trafficking promotes anticancer immunity. Adv. Sci. 10, e2206411 (2022).
Raudenska, M., Balvan, J. & Masarik, M. Crosstalk between autophagy inhibitors and endosome-related secretory pathways: a problem for autophagy-based remedy of stable cancers. Mol. Most cancers 20, 140 (2021).
Wen, Z. F. et al. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression via induction of M2-like macrophages with elevated expression of PD-L1. J. Immunother. Most cancers 6, 151 (2018).
Sanborn, R. E. et al. A pilot examine of an autologous tumor-derived autophagosome vaccine with docetaxel in sufferers with stage IV non-small cell lung most cancers. J. Immunother. Most cancers 5, 103 (2017).
Diao, L. & Liu, M. Rethinking antigen supply: most cancers vaccines primarily based on complete tumor cell/tissue lysate or complete tumor cell. Adv. Sci. 10, e2300121 (2023).
Wang, H. et al. GABARAPs regulate PI4P-dependent autophagosome:lysosome fusion. Proc. Natl Acad. Sci. USA 112, 7015–7020 (2015).
Solar, H. Q. et al. PI4P-dependent focusing on of ATG14 to mature autophagosomes. Biochemistry 61, 722–729 (2022).
Cebollero, E. et al. Phosphatidylinositol-3-phosphate clearance performs a key function in autophagosome completion. Curr. Biol. 22, 1545–1553 (2012).
van Niel, G., D’Angelo, G. & Raposo, G. Shedding gentle on the cell biology of extracellular vesicles. Nat. Rev. Mol. Cell Biol. 19, 213–228 (2018).
Martens, S., Nakamura, S. & Yoshimori, T. Phospholipids in autophagosome formation and fusion. J. Mol. Biol. 428, 4819–4827 (2016).
Zhao, Y. G., Codogno, P. & Zhang, H. Equipment, regulation and pathophysiological implications of autophagosome maturation. Nat. Rev. Mol. Cell Biol. 22, 733–750 (2021).
Shinoda, S. et al. Syntaxin 17 recruitment to mature autophagosomes is temporally regulated by PI4P accumulation. eLife 12, RP92189 (2024).
Laczkó-Dobos, H. et al. PtdIns4P is required for the autophagosomal recruitment of STX17 (syntaxin 17) to advertise lysosomal fusion. Autophagy 20, 1639–1650 (2024).
Chen, D. et al. A mammalian autophagosome maturation mechanism mediated by TECPR1 and the Atg12-Atg5 conjugate. Mol. Cell 45, 629–641 (2012).
Nakamura, S. & Yoshimori, T. New insights into autophagosome–lysosome fusion. J. Cell Sci. 130, 1209–1216 (2017).
Johnson, D., Qiao, Z., Uwadiunor, E. & Djire, A. Holdups in nitride MXene’s growth and limitations in advancing the sphere of MXene. Small 18, e2106129 (2022).
Marino, G., Niso-Santano, M., Baehrecke, E. H. & Kroemer, G. Self-consumption: the interaction of autophagy and apoptosis. Nat. Rev. Mol. Cell Biol. 15, 81–94 (2014).
Debnath, J., Gammoh, N. & Ryan, Okay. M. Autophagy and autophagy-related pathways in most cancers. Nat. Rev. Mol. Cell Biol. 24, 560–575 (2023).
Clarke, A. J. & Simon, A. Okay. Autophagy within the renewal, differentiation and homeostasis of immune cells. Nat. Rev. Immunol. 19, 170–183 (2019).
Zhao, J. et al. In situ development of nanoantioxidants on mobile vesicles for environment friendly reactive oxygen species elimination in acute inflammatory ailments. Nano At this time 40, 101282 (2021).
Murshid, A., Gong, J., Stevenson, M. A. & Calderwood, S. Okay. Warmth shock proteins and most cancers vaccines: developments previously decade and chaperoning within the decade to return. Professional Rev. Vaccines 10, 1553–1568 (2011).
Lhuillier, C. et al. Radiotherapy-exposed CD8+ and CD4+ neoantigens improve tumor management. J. Clin. Make investments. 131, e138740 (2021).
Kreiter, S. et al. Mutant MHC class II epitopes drive therapeutic immune responses to most cancers. Nature 520, 692–696 (2015).
Qin, H. et al. Growth of a most cancers vaccine utilizing in vivo click-chemistry-mediated energetic lymph node accumulation for improved immunotherapy. Adv. Mater. 33, e2006007 (2021).
Tune, T. et al. Engineering the deformability of albumin-stabilized emulsions for lymph-node vaccine supply. Adv. Mater. 33, e2100106 (2021).
Gong, T., Liu, L., Jiang, W. & Zhou, R. DAMP-sensing receptors in sterile irritation and inflammatory ailments. Nat. Rev. Immunol. 20, 95–112 (2020).
Marichal, T. et al. DNA launched from dying host cells mediates aluminum adjuvant exercise. Nat. Med. 17, 996–1002 (2011).
Gou, S. et al. Engineered nanovaccine focusing on Clec9a+ dendritic cells remarkably enhances the most cancers immunotherapy results of STING agonist. Nano Lett. 21, 9939–9950 (2021).
Xu, J. et al. A normal technique in direction of customized nanovaccines primarily based on fluoropolymers for postsurgical most cancers immunotherapy. Nat. Nanotechnol. 15, 1043–1052 (2020).
Zhao, J. et al. A minimalist binary vaccine service for customized postoperative most cancers vaccine remedy. Adv. Mater. 34, e2109254 (2022).
Lin, Z. J., Zhuo, M. J., Li, M. S., Wang, J. Y. & Zhou, Y. C. Synthesis and microstructure of layered-ternary Ti2AlN ceramic. Scr. Mater. 56, 1115–1118 (2007).
